Management Impact of 68Ga-DOTATATE PET/CT in Neuroendocrine Tumors.

Redmond-Craig Anderson Erik M Velez Bhushan Desai Hossein Jadvar

Published in: Nuclear medicine and molecular imaging (2021)

Our retrospective cohort demonstrated that 68Ga-DOTATATE PET/CT improves lesion detection over conventional imaging in 33.3% and impacts the therapeutic management in 23.8% of patients with NET.

Keyphrases

pet ct
neuroendocrine tumors
positron emission tomography
high resolution
cross sectional
mass spectrometry
photodynamic therapy
real time pcr
loop mediated isothermal amplification